Consolidated Statements of Financial Condition - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Assets [Abstract]
Cash and due from banks	$ 47,553	$ 53,581
Federal funds sold	160,155	60,932
Cash and cash equivalents	207,708	114,513
Investment securities available-for-sale (AFS), at fair value	55,747	59,928
Investment securities held-to-maturity (HTM), at amortized cost, net of allowance for credit losses of $0 and $0, respectively.	16,078	17,275
Restricted securities, at amortized cost	30,623	24,356
Loans, net of allowance for credit losses of $19,450 and $16,506, respectively	1,810,556	1,705,137
Premises and equipment, net	13,287	13,944
Accrued interest and other receivables	11,311	12,390
Computer software, net of amortization	0	14,657
Bank owned life insurance	39,507	38,318
Other Assets	43,281	34,914
Total Assets	2,228,098	2,035,432
Liabilities [Abstract]
Non-interest bearing deposits	324,307	364,606
Interest bearing demand deposits	139,780	137,128
Savings and NOW deposits	64,337	45,878
Money market deposits	560,082	442,179
Time deposits	819,288	696,336
Total deposits	1,907,794	1,686,127
Federal funds purchased	0	15,000
Subordinated debt, net	73,039	72,642
Allowance for credit losses on off-balance sheet credit exposure	287	1,009
Other Liabilities	38,987	39,137
Total Liabilities	2,020,107	1,813,915
Commitments and contingencies (Note 13)
Stockholders’ Equity
Preferred stock, $1.00 par value, 2,000,000 shares authorized non-cumulative perpetual; 28,750 issued and outstanding as of December 31, 2024 and December 31, 2023	27,263	27,263
Common stock, $4.00 par value, 15,000,000 shares authorized; issued and outstanding 7,603,765 shares (including 237,717 nonvested shares) for December 31, 2024 and 7,527,415 shares (including 228,300 nonvested shares) for December 31, 2023	29,466	29,198
Capital surplus	67,823	65,985
Retained earnings	91,150	106,549
Accumulated other comprehensive (loss)	(7,711)	(7,478)
Total Stockholders’ Equity	207,991	221,517
Total Liabilities and Stockholders’ Equity	$ 2,228,098	$ 2,035,432